Elanco Animal Health said Monday it has agreed to sell its aqua business to Merck Animal Health for $1.3 billion, a move that allows it to pay down some of its debt load and invest in new pipeline products.... Read More
The NBA All-Star Game is still two weeks away, but commercial real estate brokers have been busy taking calls, showing spaces and girding for what might be the largest crowd of people downtown in a decade. Brokers are filling vacant retail spaces with...... Read More
In the face of Indiana’s ongoing workforce shortage, drugmaker Eli Lilly and Co. is teaming up with Indiana University to launch a new co-op partnership with the aim of beefing up the state’s talent pipeline.... Read More
Vince Wong, a former executive at Roche Diagnostics and a biotech startup, has been chosen as the new president and CEO of BioCrossroads, an Indianapolis-based group that promotes and invests in the state’s $77 billion life sciences sector.... Read More
Across Indiana, hundreds of not-for-profits count on individual gifts for a significant portion of their revenue. And to land the big gifts, institutions are increasingly turning to hands-on, in-person events in the hopes of building long-term relationships.... Read More
The planned retirement of numerous, large coal-fired generating units around Indiana could be slowed under a bill that would require electric utilities to ask state regulators for permission before they shut them down.... Read More
The move comes as the federal government and private insurers are trying to shorten the timeline for approving medical care for millions of Americans for a wide range of procedures, from surgeries and specialty care to CT scans and physical therapy.... Read More
Indiana’s pharmaceutical and medical device sectors, long touted as major contributors to the state’s economy, are starting to lag the nation in growth and market share and will require a focused effort to stay competitive, according to a new report.... Read More
A Nevada-based biotech company is suing Eli Lilly and Co., saying the Indianapolis-based drugmaker is refusing to pay royalties on patented technology it claims is used in Lilly’s pending new treatment for Alzheimer’s disease.... Read More
RayzeBio Inc., a San Diego-based company that is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment, has agreed to be acquired by pharmaceutical company Bristol Myers Squibb for $4.1 billion.... Read More
